Synthesis and biologic examination of some derivatives of 2,2'-anhydro-1-(beta-d-arabinofuranosyl)cytosine hydrochloride (NSC-145668). 1974

J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri

UI MeSH Term Description Entries
D007455 Iodine A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically. Iodine-127,Iodine 127
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004267 DNA Viruses Viruses whose nucleic acid is DNA. DNA Virus,Virus, DNA,Viruses, DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
June 1973, Biochemical and biophysical research communications,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
June 1979, Journal of medicinal chemistry,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
March 1977, Journal of medicinal chemistry,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
September 1975, Cancer research,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
July 1976, Cancer treatment reports,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
August 1975, Annals of the New York Academy of Sciences,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
July 1977, Cancer treatment reports,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
August 1975, Annals of the New York Academy of Sciences,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
January 1991, Nucleic acids symposium series,
J G Moffatt, and E K Hamamura, and A F Russell, and M Prystasz, and J P Verheyden, and K Yamaguchi, and N Uchida, and K Sato, and S Nishiyama, and O Shiratori, and K Katagiri
January 1981, Chemico-biological interactions,
Copied contents to your clipboard!